Cannacord analyst Richard Close raised his price target for Cerner to $77 from $68 and reiterated a Buy rating. In a research note to investors, Close says Cerner’s attention to driving shareholder returns by implementing a $1.5B stock buyback, a dividend, and refocusing on profitable innovation and growth should lead to share appreciation.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.